Evidence map›Paper›PMID 27512997›Full record

ArticlePloS one2016

Understanding the Pathogenicity of Burkholderia contaminans, an Emerging Pathogen in Cystic Fibrosis.

Jaroslav Nunvar, Lucie Kalferstova, Ruhi A M Bloodworth, Michal Kolar, Jose Degrossi, Silvina Lubovich, Silvia T Cardona, Pavel Drevinek

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 43 citations in OpenAlex.

  1. Draft genome sequences ofMicrobiology resource announcements · 2026
    Article
  2. Total Synthesis ofJournal of the American Chemical Society · 2026
    Article
  3. Review
  4. Microorganisms · 2025
    Review
  5. Article
  6. Colony morphotype variation inJournal of bacteriology · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Drought TolerantBiology · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Frontiers in cellular and infection microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Jaroslav NunvarDepartment of Medical Microbiology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Lucie KalferstovaDepartment of Medical Microbiology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Ruhi A M BloodworthDepartment of Medical Microbiology & Infectious Disease, University of Manitoba, Winnipeg, Canada.
Michal KolarLaboratory of Genomics and Bioinformatics, Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
Jose DegrossiSchool of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.
Silvina LubovichCentro Respiratorio Dr. A. Alvarez, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina.
Silvia T CardonaDepartment of Medical Microbiology & Infectious Disease, University of Manitoba, Winnipeg, Canada.
Pavel DrevinekDepartment of Medical Microbiology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Charles University · CZUniversity of Manitoba · CACzech Academy of Sciences, Institute of Molecular Genetics · CZHospital General de Niños Ricardo Gutierrez · ARUniversity of Buenos Aires · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several bacterial species from the Burkholderia cepacia complex (Bcc) are feared opportunistic pathogens that lead to debilitating lung infections with a high risk of developing fatal septicemia in cystic fibrosis (CF) patients. However, the pathogenic potential of other Bcc species is yet unknown. To elucidate clinical relevance of Burkholderia contaminans, a species frequently isolated from CF respiratory samples in Ibero-American countries, we aimed to identify its key virulence factors possibly linked with an unfavorable clinical outcome. We performed a genome-wide comparative analysis of two isolates of B. contaminans ST872 from sputum and blood culture of a female CF patient in Argentina. RNA-seq data showed significant changes in expression for quorum sensing-regulated virulence factors and motility and chemotaxis. Furthermore, we detected expression changes in a recently described low-oxygen-activated (lxa) locus which encodes stress-related proteins, and for two clusters responsible for the biosynthesis of antifungal and hemolytic compounds pyrrolnitrin and occidiofungin. Based on phenotypic assays that confirmed changes in motility and in proteolytic, hemolytic and antifungal activities, we were able to distinguish two phenotypes of B. contaminans that coexisted in the host and entered her bloodstream. Whole genome sequencing revealed that the sputum and bloodstream isolates (each representing a distinct phenotype) differed by over 1,400 mutations as a result of a mismatch repair-deficient hypermutable state of the sputum isolate. The inferred lack of purifying selection against nonsynonymous mutations and the high rate of pseudogenization in the derived isolate indicated limited evolutionary pressure during evolution in the nutrient-rich, stable CF sputum environment. The present study is the first to examine the genomic and transcriptomic differences between longitudinal isolates of B. contaminans. Detected activity of a number of putative virulence factors implies a genuine pathogenic nature of this novel Bcc species.

Indexed as

Bacterial ProteinsBurkholderiaBurkholderia InfectionsChildCommunicable Diseases, EmergingCystic FibrosisFemaleGene Expression ProfilingGene Expression Regulation, BacterialGenome, BacterialHumansOpportunistic InfectionsQuorum SensingVirulenceVirulence FactorsBacterial ProteinsVirulence Factors

Identifiers

PMID27512997
PMCPMC4981469
OpenAlexW2511671681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.